PNC Financial Services Group
IONS icon

PNC Financial Services Group’s Ionis Pharmaceuticals IONS Stock Holding History

PNC Financial Services Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
13,545
-271
-2% -$21.4K ﹤0.01% 1290
2025
Q4 		$1.09M Buy
13,816
+1,703
+14% +$128K ﹤0.01% 1223
2025
Q3 		$792K Buy
12,113
+702
+6% +$34.3K ﹤0.01% 1363
2025
Q2 		$451K Buy
11,411
+424
+4% +$13.9K ﹤0.01% 1635
2025
Q1 		$331K Sell
10,987
-7
-0.1% -$229 ﹤0.01% 1825
2024
Q4 		$384K Buy
10,994
+1,101
+11% +$41.2K ﹤0.01% 1730
2024
Q3 		$396K Buy
9,893
+532
+6% +$24.8K ﹤0.01% 1708
2024
Q2 		$446K Buy
9,361
+542
+6% +$22.2K ﹤0.01% 1564
2024
Q1 		$382K Buy
8,819
+441
+5% +$21K ﹤0.01% 1706
2023
Q4 		$424K Buy
8,378
+202
+2% +$9.68K ﹤0.01% 1628
2023
Q3 		$371K Sell
8,176
-195
-2% -$8.04K ﹤0.01% 1683
2023
Q2 		$343K Sell
8,371
-10
-0.1% -$384 ﹤0.01% 1819
2023
Q1 		$300K Sell
8,381
-886
-10% -$33.3K ﹤0.01% 1890
2022
Q4 		$350K Sell
9,267
-562
-6% -$23.6K ﹤0.01% 1745
2022
Q3 		$435K Sell
9,829
-153
-2% -$6.45K ﹤0.01% 1590
2022
Q2 		$370K Buy
9,982
+320
+3% +$12.1K ﹤0.01% 1725
2022
Q1 		$358K Buy
9,662
+831
+9% +$27.2K ﹤0.01% 1890
2021
Q4 		$269K Buy
8,831
+32
+0.4% +$1.01K ﹤0.01% 2073
2021
Q3 		$294K Sell
8,799
-548
-6% -$20.6K ﹤0.01% 1951
2021
Q2 		$373K Sell
9,347
-11
-0.1% -$431 ﹤0.01% 1810
2021
Q1 		$420K Buy
9,358
+752
+9% +$41.9K ﹤0.01% 1690
2020
Q4 		$487K Buy
8,606
+66
+0.8% +$3.29K ﹤0.01% 1499
2020
Q3 		$405K Sell
8,540
-45
-0.5% -$2.5K ﹤0.01% 1472
2020
Q2 		$507K Buy
8,585
+1
+0% +$56 ﹤0.01% 1381
2020
Q1 		$405K Sell
8,584
-349
-4% -$19.5K ﹤0.01% 1402
2019
Q4 		$539K Buy
8,933
+540
+6% +$32.2K ﹤0.01% 1432
2019
Q3 		$502K Buy
8,393
+15
+0.2% +$978 ﹤0.01% 1590
2019
Q2 		$539K Buy
8,378
+166
+2% +$11.7K ﹤0.01% 1579
2019
Q1 		$667K Sell
8,212
-300
-4% -$19.4K ﹤0.01% 1485
2018
Q4 		$460K Sell
8,512
-46
-0.5% -$2.35K ﹤0.01% 1593
2018
Q3 		$442K Buy
8,558
+45
+0.5% +$2.11K ﹤0.01% 1734
2018
Q2 		$354K Buy
8,513
+53
+0.6% +$2.35K ﹤0.01% 1853
2018
Q1 		$374K Buy
8,460
+19
+0.2% +$965 ﹤0.01% 1803
2017
Q4 		$424K Buy
8,441
+192
+2% +$10.5K ﹤0.01% 1735
2017
Q3 		$419K Buy
8,249
+20
+0.2% +$1.05K ﹤0.01% 1720
2017
Q2 		$419K Sell
8,229
-586
-7% -$27.3K ﹤0.01% 1716
2017
Q1 		$354K Sell
8,815
-82
-0.9% -$3.68K ﹤0.01% 1805
2016
Q4 		$425K Buy
8,897
+1,020
+13% +$40.4K ﹤0.01% 1675
2016
Q3 		$290K Sell
7,877
-243
-3% -$7.6K ﹤0.01% 1881
2016
Q2 		$189K Sell
8,120
-4,896
-38% -$158K ﹤0.01% 2130
2016
Q1 		$526K Sell
13,016
-14,695
-53% -$597K ﹤0.01% 1521
2015
Q4 		$1.72M Buy
27,711
+787
+3% +$42.5K ﹤0.01% 973
2015
Q3 		$1.09M Buy
26,924
+1,771
+7% +$91.7K ﹤0.01% 1193
2015
Q2 		$1.45M Sell
25,153
-446
-2% -$28.4K ﹤0.01% 1104
2015
Q1 		$1.63M Buy
25,599
+1,170
+5% +$79.4K ﹤0.01% 1048
2014
Q4 		$1.51M Buy
24,429
+2,552
+12% +$126K ﹤0.01% 1031
2014
Q3 		$849K Sell
21,877
-3,000
-12% -$106K ﹤0.01% 1184
2014
Q2 		$857K Sell
24,877
-7,244
-23% -$228K ﹤0.01% 1151
2014
Q1 		$1.39M Sell
32,121
-374
-1% -$18.1K ﹤0.01% 962
2013
Q4 		$1.29M Buy
32,495
+3,481
+12% +$124K ﹤0.01% 953
2013
Q3 		$1.09M Buy
29,014
+10,188
+54% +$304K ﹤0.01% 985
2013
Q2 		$505K Buy
+18,826
New +$400K ﹤0.01% 1282

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's IONS Position: Q1 2026 in Review

PNC Financial Services Group reduced its Ionis Pharmaceuticals (IONS) stake by 2% in Q1 2026, selling an estimated $21.4K and leaving 13,545 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

PNC Financial Services Group first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.72M in Q4 2015. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • PNC Financial Services Group held 13,545 shares of Ionis Pharmaceuticals worth $1.02M as of Q1 2026.
  • PNC Financial Services Group sold 271 Ionis Pharmaceuticals shares in Q1 2026, an estimated $21.4K.
  • Ionis Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #1290 holding.
  • PNC Financial Services Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Ionis Pharmaceuticals position peaked at $1.72M in Q4 2015.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.